- Targeted Pharmacological Interventions for Autism: A Double-Blind, Placebo-Controlled Study of Atomoxetine in Children and Adolescents with Autism
The Massachusetts General Hospital for Children at the Lurie Center is conducting a research study for children and adolescents ages 5-15 who have autistic disorder, Asperger’s disorder, or pervasive developmental disorder, not otherwise specified and who also have symptoms such as: overactivity, impulsivity, and/or inattention. The study involves a non-stimulant medication and clinic visits at no charge. If you would like to find out more about this research study at the Lurie Center, please contact us at (781) 860-1711 or LurieCenterResearch@partners.org.
Institution – MGH - Massachusetts General Hospital, Boston, MA
Principal Investigator – Christopher J McDougle, MD
For further information about enrolling a patient in this trial, contact the person below.
Name – Jennifer Mullett, RN
Email – LurieCenterResearch@partners.org
Phone – 781-860-1711